Jorge Caicedo

6PUBLICATIONS
20CO-AUTHORS
HaematologyCardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 13, 2026
Bleeding rates, healthcare utilization, and costs among patients with hemophilia a without inhibitors treated with concomitant octocog alfa or extended half-life factor VIII while on emicizumab prophylaxis.

Caitlin Montcrieff, Jorge Caicedo, Alicia Cerretani

|May 15, 2023
Real-world healthcare costs and resource utilization in patients with von Willebrand disease and angiodysplasia.

N T Connell, J Caicedo, N Nieto

|May 06, 2023
Real-world analysis of patients with haemophilia A and haemophilia A carriers in the United States: Demographics, clinical characteristics and costs.

Katharine Batt, Shan Xing, Maja Kuharic

|Apr 28, 2023
A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors.

Miguel Escobar, Michael Bullano, Ali G Mokdad

|Mar 29, 2023
Impact of switching prophylaxis treatment from factor VIII to emicizumab in hemophilia A patients without inhibitors.

Miguel Escobar, Neha Agrawal, Sagnik Chatterjee

|Jul 26, 2022
A real-world study comparing pre-post billed annualized bleed rates and total cost of care among non-inhibitor patients with hemophilia A switching from FVIII prophylaxis to emicizumab.

Katharine Batt, Bob G Schultz, Jorge Caicedo

Pageof 1

Frequent Collaborators

6 joint publications

Michael Bullano

4 joint publications

Bob G Schultz

3 joint publications

Sagnik Chatterjee

2 joint publications

Katharine Batt